Brief: Neuroscientific Biopharmaceuticals Announces Resignation Of CEO
09/09/2022 02:44
Sept 9 (Reuters) - NeuroScientific Biopharmaceuticals Ltd
NSB.AX :
* RESIGNATION OF ITS CEO AND MANAGING DIRECTOR, MATT
LIDDELOW
Source text for Eikon: ID:nASXc3k9xs
Further company coverage: NSB.AX
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO